Top compounds associated with response to KCNH3


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.2 3e-11
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 5e-10
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.2 1e-09
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-09
mRNA PX-12 CTRPv2 pan-cancer AAC 0.17 2e-09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.19 4e-09
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 6e-09
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 7e-09
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-08
Download CSV